Results 251 to 260 of about 145,153 (301)

Cutaneous calcinosis-an unusual complication of intravenous phosphate administration

Clinical and Experimental Dermatology, 1993
The case of an 80-year-old woman who developed extensive cutaneous calcification following intravenous phosphate administration is presented. Also the circumstances under which cutaneous calcification may occur are discussed.
C M Mills, A G Knight
exaly   +3 more sources

Cutaneous Administration of Nitroglycerin: A Review

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1983
Chronic administration of nitroglycerin may have important therapeutic effects in patients with angina, acute myocardial infarction, congestive heart failure and peripheral vascular disease. Because of unpredictable oral absorption and short duration of action, topical preparations provide an alternative mode of administration.
M T, Olivari, J N, Cohn
openaire   +2 more sources

Cutaneous toxicity following the administration of dactinomycin

Medical and Pediatric Oncology, 1997
Dactinomycin (AMD) is an effective drug in the management of several malignant disorders and has been used for almost 40 years. Skin and subcutaneous toxicities following extravasation are well known and can be harmful. Similarly radiation-recall is a well established phenomenon following the administration of AMD.
M J, Coppes, K, Jorgenson, J P, Arlette
openaire   +2 more sources

Cutaneous reaction associated with weekly docetaxel administration

Journal of Oncology Pharmacy Practice, 2008
Background. Docetaxel-based chemotherapy will remain clinically relevant and many of our patients will continue to receive the drug. In a recent phase 2 study of docetaxel 35 mg/m2 (weekly) in patients with metastatic breast cancer, the incidence of grade 3 cutaneous toxicity is 19%.
Chew, L., Chuen, V.S.L.
openaire   +2 more sources

Cutaneous Lesion Induced by a Subcutaneous Administration of Bortezomib

Clinical Lymphoma Myeloma and Leukemia, 2012
Introduction A 78-year-old man presented to our hospital with an indurated, painful lesion on the abdominal wall at the site of a recent subcutaneous (SC) bortezomib injection. The patient was diagnosed with multiple myeloma (MM) in 2007 after a bone marrow biopsy was done as part of anemia workup.
Karam M, Obeid, Richard, Ferrara, Mamta, Sharma   +2 more
openaire   +2 more sources

Cutaneous reactions to Adalimumab administration

Irish medical journal, 2011
Leinster
Downes, MR, Prendeville, S, Kiely, C
openaire   +3 more sources